Gabapentin 100 mg, Aurobindo D 02 Pill – white capsule/oblong, 16mm

Pill with imprint D 02 is White, Capsule/Oblong and has been identified as Gabapentin 100 mg. It is supplied by Aurobindo Pharma.

Gabapentin is used in the treatment of Back Pain; Postherpetic Neuralgia; Epilepsy; Chronic Pain; Seizures and belongs to the drug class gamma-aminobutyric acid analogs.

Risk cannot be ruled out during pregnancy. Gabapentin 100 mg is not a controlled substance under the Controlled Substances Act (CSA).

Gabapentin

Imprint
D 02
Strength
100 mg
Color
White
Size
16.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Gamma-aminobutyric acid analogs
Pregnancy Category
C – Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma
Inactive Ingredients
corn starch, magnesium silicate, gelatin, titanium dioxide, sodium lauryl sulfate, ferrosoferric oxide, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65862-0198 Aurobindo Pharma Limited
16714-0661 NorthStar Rx LLC

Gabapentin 600mg

Gabapentin 600mg is a prescription medication typically used to treat conditions such as epilepsy, neuropathic pain, and certain types of seizures. If your healthcare provider has prescribed gabapentin 600mg for you, it’s important to follow their instructions carefully. Here are some general guidelines for taking gabapentin 600mg:

  1. Dosage: Take gabapentin exactly as prescribed by your doctor. The typical starting dose for adults is 300mg taken orally twice a day, with the dose gradually increased as needed under your doctor’s supervision. Your doctor will determine the appropriate dose based on your medical condition and response to treatment.
  2. Administration: Gabapentin tablets should be taken orally with plenty of water. Swallow the tablet whole; do not crush, chew, or break it. You can take gabapentin with or without food, but it’s important to take it consistently, either always with food or always on an empty stomach, to maintain consistent drug levels in your body.
  3. Schedule: Take gabapentin at evenly spaced intervals to maintain a constant level of medication in your body. This helps ensure its effectiveness in managing your condition. If you are taking gabapentin more than once a day, try to take it at the same times each day to establish a routine.
  4. Do not stop suddenly: Do not stop taking gabapentin abruptly without consulting your doctor, even if you feel better. Suddenly stopping gabapentin can cause withdrawal symptoms or worsen your condition. Your doctor may need to gradually taper your dose to safely discontinue the medication.
  5. Interactions: Inform your doctor about all medications, supplements, and herbal products you are taking, as gabapentin can interact with certain drugs. This includes over-the-counter medications.
  6. Pregnancy and breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of taking gabapentin with your doctor. Gabapentin may not be suitable during pregnancy or while breastfeeding.
  7. If you are between the ages of 18 and 60, take no other medications, and have no other medical conditions, you are more likely to experience the following side effects with gabapentin:
    • Common Side Effects: Dizziness, drowsiness, tiredness, fever, and nystagmus (rapid, uncontrollable eye movements). Gabapentin-induced drowsiness can impair your ability to drive or operate machinery. Alcohol and other sedatives can enhance this effect.
    • Behavioral Changes in Children: When used to treat epilepsy in children aged three to twelve, gabapentin may cause behavioral problems, hostility, aggression, or thought disturbances.
    • Other Side Effects: Blurred vision, amblyopia (lazy eye), dry mouth, peripheral edema (fluid retention in feet and hands), tremor, sexual dysfunction, and gastrointestinal disturbances.
    • Titration: Gabapentin should be titrated up slowly to reduce the risk of side effects, although this may delay the onset of its effects.
    • Mental Health Risks: Similar to other anticonvulsants, gabapentin may increase the risk of depression and suicidal thoughts, especially in young adults under 24.
    • Discontinuation Syndrome: Abruptly stopping gabapentin can cause withdrawal symptoms such as anxiety, insomnia, nausea, pain, and sweating. It should be tapered off slowly under medical supervision.
    • Kidney Disease: The dosage needs to be reduced for individuals with kidney disease.
    • Hypersensitivity Reactions: Rarely, hypersensitivity reactions can occur, including fever, rash, swollen lymph nodes, swollen facial features, or throat swelling.
    • Drug Interactions: Gabapentin may interact with other medications, including antacids, hydrocodone, morphine, and other sedatives, potentially causing increased sedation or dizziness. It may also cause false-positive results on some urinary protein tests.
    • Misuse and Abuse: There have been reports of gabapentin misuse and abuse, especially in individuals with a history of drug abuse.
    • Administration: Gabapentin typically requires three times daily administration due to its short duration of effect. However, gabapentin enacarbil (brand name Horizant) is a long-acting prodrug that only requires once-daily dosing.
    • Seizure Disorders: Gabapentin is only effective for partial-onset seizures and not for other types of seizure disorders.
    • Interchangeability: Some branded and generic forms of gabapentin are not interchangeable.

Aurobindo Pharma

Aurobindo Pharma is a major Indian multinational pharmaceutical company that develops, manufactures, and distributes a wide range of generic pharmaceuticals and active pharmaceutical ingredients (APIs). Here’s a detailed overview of the company:

Company Overview

  1. Founding and History:
    • Founded: In 1986 by Mr. P. V. Ramprasad Reddy and Mr. K. Nityananda Reddy.
    • Headquarters: Hyderabad, Telangana, India.
    • Growth: Aurobindo Pharma has grown rapidly since its inception and is now one of the largest pharmaceutical companies in India and a significant player in the global market.
  2. Operations and Facilities:
    • Manufacturing: Aurobindo has several manufacturing facilities across India, the United States, and other countries. These facilities are compliant with international regulatory standards such as the U.S. FDA, EMA, and WHO.
    • Research and Development: The company invests heavily in R&D with multiple state-of-the-art facilities in India and overseas, focusing on developing generic formulations, APIs, and biosimilars.
  3. Product Portfolio:
    • Generics: Aurobindo offers a broad range of generic medications covering various therapeutic areas, including antibiotics, antiretrovirals, cardiovascular, central nervous system, gastroenterology, and anti-diabetics.
    • APIs: The company is a significant producer of active pharmaceutical ingredients used both in-house and by other pharmaceutical manufacturers.
    • Biosimilars and Specialty Products: Aurobindo is also involved in developing biosimilars and specialty pharmaceuticals, expanding its product offerings beyond traditional generics.
  4. Global Presence:
    • Market Reach: Aurobindo Pharma has a significant presence in over 150 countries, including key markets like the United States, Europe, and emerging markets in Asia and Africa.
    • Subsidiaries: The company operates through numerous subsidiaries and joint ventures worldwide to strengthen its market position and distribution network.

Key Areas of Operation

  1. Regulatory Compliance:
    • Quality Standards: Aurobindo adheres to stringent quality control measures and regulatory requirements to ensure the safety, efficacy, and quality of its products.
    • Approvals and Inspections: The company regularly undergoes inspections by regulatory authorities such as the FDA, EMA, and others to maintain compliance with international standards.
  2. Research and Development:
    • Innovation: Aurobindo’s R&D efforts are focused on developing complex generics, novel drug delivery systems, and biosimilars.
    • Pipeline: The company has a robust pipeline of products in various stages of development, aimed at addressing unmet medical needs and expanding its market offerings.
  3. Manufacturing Excellence:
    • Capacity: Aurobindo’s manufacturing facilities are equipped with advanced technology and have large production capacities, enabling the company to meet global demand efficiently.
    • Vertical Integration: The company’s vertical integration in API and formulation manufacturing provides cost advantages and ensures consistent supply chain management.
  4. Strategic Acquisitions and Partnerships:
    • Expansion: Aurobindo has expanded its global footprint through strategic acquisitions and partnerships, enhancing its product portfolio and market access.
    • Notable Acquisitions: Examples include the acquisition of Sandoz’s U.S. dermatology and oral solids businesses, and Apotex’s businesses in select European countries.

Corporate Responsibility

  1. Sustainability:
    • Environmental Practices: Aurobindo is committed to sustainable manufacturing practices, including reducing its carbon footprint, efficient waste management, and water conservation efforts.
    • Community Initiatives: The company engages in various CSR activities focused on healthcare, education, and community development.
  2. Employee Welfare:
    • Workplace Safety: Aurobindo places a strong emphasis on workplace safety, health, and well-being of its employees.
    • Training and Development: The company invests in continuous training and professional development for its workforce.

Conclusion

Aurobindo Pharma is a prominent global pharmaceutical company known for its extensive range of generic medications and APIs. With a strong focus on research and development, regulatory compliance, and strategic growth, Aurobindo continues to expand its global presence and product portfolio. The company’s commitment to quality, innovation, and sustainability positions it as a key player in the pharmaceutical industry, contributing to making healthcare more affordable and accessible worldwide.

Gabapentin 800mg – G 13 Pill, Glenmark Generics Inc. – white oval, 19mm

Pill with imprint G 13 is White, Oval and has been identified as Gabapentin 800 mg. It is supplied by Glenmark Generics Inc.

Gabapentin is used in the treatment of Back Pain; Postherpetic Neuralgia; Epilepsy; Chronic Pain; Seizures and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Gabapentin 800 mg is not a controlled substance under the Controlled Substances Act (CSA).

Gabapentin

Imprint
G 13
Strength
800 mg
Color
White
Size
19.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Gamma-aminobutyric acid analogs
Pregnancy Category
C – Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Glenmark Generics Inc.
Inactive Ingredients
corn starch, copovidone, poloxamer 407, magnesium stearate, titanium dioxide, magnesium silicate, polysorbate 80, water

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
68462-0127 Glenmark Pharmaceuticals Inc.
54868-5195 (Discontinued) Physicians Total Care Inc. (repackager)

What is Gabapentin and How to Use it ?

Gabapentin is a medication primarily used to treat seizures (epilepsy) and nerve pain (neuropathic pain). It belongs to a class of medications known as anticonvulsants or antiepileptic drugs. Gabapentin works by affecting certain chemicals and neurotransmitters in the brain involved in seizures and nerve pain.

Here’s how gabapentin is typically used:

  1. Seizures (Epilepsy): Gabapentin is commonly prescribed as an adjunctive treatment for partial seizures in adults and children aged 3 years and older. It is often used in combination with other antiepileptic medications to help control seizures.
  2. Nerve Pain (Neuropathic Pain): Gabapentin is also frequently used to treat various types of nerve pain, including diabetic neuropathy, postherpetic neuralgia (nerve pain following shingles), and peripheral neuropathy. It is effective in relieving shooting or burning sensations, tingling, or numbness associated with nerve damage.

Gabapentin is usually taken orally in the form of capsules, tablets, or an oral solution. Here are some general guidelines for using gabapentin:

  1. Dosage: The dosage of gabapentin varies depending on the individual’s medical condition, age, and response to treatment. It’s essential to follow your doctor’s instructions and the dosage prescribed on the medication label carefully.
  2. Administration: Gabapentin is typically taken by mouth with or without food. Swallow the capsule or tablet whole with a full glass of water. Do not crush, chew, or break the tablet or capsule unless directed to do so by your doctor.
  3. Timing: Take gabapentin exactly as prescribed by your doctor. It’s important to take it regularly and at the same times each day to maintain a consistent level of the medication in your body.
  4. Gradual Dosing: If you are starting gabapentin treatment or increasing the dosage, your doctor may recommend starting with a low dose and gradually increasing it over time to minimize side effects.
  5. Duration of Treatment: Continue taking gabapentin for the full duration of treatment prescribed by your doctor, even if you start to feel better. Stopping gabapentin suddenly can increase the risk of seizures or other withdrawal symptoms.
  6. Monitor Side Effects: Pay attention to any side effects you may experience while taking gabapentin and report them to your doctor. Common side effects may include dizziness, drowsiness, fatigue, and weight gain.
  7. Storage: Store gabapentin at room temperature away from moisture and heat. Keep it out of reach of children and pets.

It’s important to note that gabapentin can interact with other medications, so it’s essential to inform your doctor about all the medications you are taking, including prescription drugs, over-the-counter medications, and supplements. Additionally, never adjust your gabapentin dosage or stop taking it without consulting your doctor first, as sudden changes can lead to serious complications.

Glenmark Generics Inc.

Glenmark Generics Inc. is a subsidiary of Glenmark Pharmaceuticals Ltd., an Indian multinational pharmaceutical company headquartered in Mumbai, India. Glenmark Generics focuses on developing, manufacturing, and distributing generic pharmaceutical products for the U.S. and other international markets. Here is a detailed overview of Glenmark Generics Inc.:

Company Overview

  1. Parent Company: Glenmark Pharmaceuticals Ltd.
    • Founded: 1977 by Gracias Saldanha.
    • Headquarters: Mumbai, Maharashtra, India.
    • Global Presence: Glenmark Pharmaceuticals operates in over 50 countries with a strong presence in North America, Europe, and Asia.
  2. Glenmark Generics Inc.:
    • Focus: Specializes in the development, manufacture, and distribution of generic pharmaceutical products.
    • Market: Primarily targets the U.S. market, one of the largest and most regulated pharmaceutical markets globally.
  3. Product Portfolio:
    • Generics: Glenmark Generics offers a wide range of generic medications across various therapeutic categories, including dermatology, respiratory, oncology, cardiovascular, and central nervous system (CNS) disorders.
    • Specialty Products: The company also works on developing specialty and complex generics, including injectables and inhalation products.
  4. Manufacturing and R&D:
    • Facilities: Glenmark has multiple manufacturing facilities in India and other countries that comply with international regulatory standards such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and others.
    • Research and Development: Significant investment in R&D to develop new generic formulations and improve existing ones. Glenmark has several R&D centers globally, including a notable facility in Mahape, Navi Mumbai.
  5. Regulatory Compliance:
    • Quality Standards: Glenmark Generics ensures adherence to stringent quality control and regulatory standards set by global regulatory bodies, including the FDA.
    • Inspections and Approvals: The company regularly undergoes inspections and audits to maintain compliance with Good Manufacturing Practices (GMP).
  6. Market Strategy:
    • Product Launches: Glenmark Generics is known for timely launches of first-to-file generic products, which can be highly profitable due to market exclusivity periods.
    • Competitive Pricing: Focus on providing cost-effective alternatives to brand-name medications, making healthcare more affordable.
  7. Acquisitions and Partnerships:
    • Glenmark Pharmaceuticals has expanded its generics business through strategic acquisitions and partnerships, enhancing its product portfolio and market reach.
  8. Corporate Responsibility:
    • Sustainability: Glenmark is committed to sustainable practices in its operations, focusing on environmental protection, efficient use of resources, and reducing its carbon footprint.
    • Community Engagement: The company engages in various corporate social responsibility (CSR) activities, including healthcare initiatives, education, and community development projects.

Key Achievements and Initiatives

  1. Innovation in Generics: Glenmark Generics has introduced several first-to-market generics, providing affordable alternatives to expensive brand-name drugs.
  2. Global Expansion: The company has significantly expanded its footprint in the U.S. and other international markets, establishing itself as a reputable player in the generic pharmaceuticals industry.
  3. R&D Excellence: With a strong focus on research and development, Glenmark has developed numerous complex generics and innovative drug delivery systems.

Conclusion

Glenmark Generics Inc., a subsidiary of Glenmark Pharmaceuticals Ltd., plays a crucial role in the global generics market, particularly in the U.S. With a broad product portfolio, rigorous regulatory compliance, and a strong commitment to quality and innovation, Glenmark Generics continues to be a significant contributor to making healthcare more accessible and affordable worldwide. The company’s ongoing efforts in research and development, along with strategic market strategies, position it well for continued growth and success in the pharmaceutical industry.

Gabapentin 600mg, Aurobindo Pharma USA, D 24 Pill – white oval

D 24 Pill – white oval, 17mm

Pill with imprint D 24 is White, Oval and has been identified as Gabapentin 600 mg. It is supplied by Aurobindo Pharma USA, Inc.

Gabapentin is used in the treatment of Back Pain; Postherpetic Neuralgia; Epilepsy; Chronic Pain; Seizures and belongs to the drug class gamma-aminobutyric acid analogs. Risk cannot be ruled out during pregnancy. Gabapentin 600 mg is not a controlled substance under the Controlled Substances Act (CSA).

Gabapentin 600mg, Aurobindo Pharma USA, D 24 Pill - white oval
Gabapentin 600mg, Aurobindo Pharma USA, D 24 Pill – white oval

Gabapentin

Imprint
D 24
Strength
600 mg
Color
White
Size
17.00 mm
Shape
Oval
Availability
Prescription only
Drug Class
Gamma-aminobutyric acid analogs
Pregnancy Category
C – Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Aurobindo Pharma USA, Inc.
Inactive Ingredients
copovidone, corn starch, crospovidone, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, magnesium silicate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
65862-0523 Aurobindo Pharma Limited
16714-0330 NorthStar Rx LLC

Gabapentin 600mg

Gabapentin 600mg is a prescription medication typically used to treat conditions such as epilepsy, neuropathic pain, and certain types of seizures. If your healthcare provider has prescribed gabapentin 600mg for you, it’s important to follow their instructions carefully. Here are some general guidelines for taking gabapentin 600mg:

  1. Dosage: Take gabapentin exactly as prescribed by your doctor. The typical starting dose for adults is 300mg taken orally twice a day, with the dose gradually increased as needed under your doctor’s supervision. Your doctor will determine the appropriate dose based on your medical condition and response to treatment.
  2. Administration: Gabapentin tablets should be taken orally with plenty of water. Swallow the tablet whole; do not crush, chew, or break it. You can take gabapentin with or without food, but it’s important to take it consistently, either always with food or always on an empty stomach, to maintain consistent drug levels in your body.
  3. Schedule: Take gabapentin at evenly spaced intervals to maintain a constant level of medication in your body. This helps ensure its effectiveness in managing your condition. If you are taking gabapentin more than once a day, try to take it at the same times each day to establish a routine.
  4. Do not stop suddenly: Do not stop taking gabapentin abruptly without consulting your doctor, even if you feel better. Suddenly stopping gabapentin can cause withdrawal symptoms or worsen your condition. Your doctor may need to gradually taper your dose to safely discontinue the medication.
  5. Side effects: Be aware of potential side effects of gabapentin, which may include dizziness, drowsiness, fatigue, blurred vision, weight gain, or swelling in the extremities. If you experience severe or persistent side effects, contact your doctor.
  6. Interactions: Inform your doctor about all medications, supplements, and herbal products you are taking, as gabapentin can interact with certain drugs. This includes over-the-counter medications.
  7. Pregnancy and breastfeeding: If you are pregnant, planning to become pregnant, or breastfeeding, discuss the risks and benefits of taking gabapentin with your doctor. Gabapentin may not be suitable during pregnancy or while breastfeeding.

Aurobindo Pharma

Aurobindo Pharma is a major Indian multinational pharmaceutical company that develops, manufactures, and distributes a wide range of generic pharmaceuticals and active pharmaceutical ingredients (APIs). Here’s a detailed overview of the company:

Company Overview

  1. Founding and History:
    • Founded: In 1986 by Mr. P. V. Ramprasad Reddy and Mr. K. Nityananda Reddy.
    • Headquarters: Hyderabad, Telangana, India.
    • Growth: Aurobindo Pharma has grown rapidly since its inception and is now one of the largest pharmaceutical companies in India and a significant player in the global market.
  2. Operations and Facilities:
    • Manufacturing: Aurobindo has several manufacturing facilities across India, the United States, and other countries. These facilities are compliant with international regulatory standards such as the U.S. FDA, EMA, and WHO.
    • Research and Development: The company invests heavily in R&D with multiple state-of-the-art facilities in India and overseas, focusing on developing generic formulations, APIs, and biosimilars.
  3. Product Portfolio:
    • Generics: Aurobindo offers a broad range of generic medications covering various therapeutic areas, including antibiotics, antiretrovirals, cardiovascular, central nervous system, gastroenterology, and anti-diabetics.
    • APIs: The company is a significant producer of active pharmaceutical ingredients used both in-house and by other pharmaceutical manufacturers.
    • Biosimilars and Specialty Products: Aurobindo is also involved in developing biosimilars and specialty pharmaceuticals, expanding its product offerings beyond traditional generics.
  4. Global Presence:
    • Market Reach: Aurobindo Pharma has a significant presence in over 150 countries, including key markets like the United States, Europe, and emerging markets in Asia and Africa.
    • Subsidiaries: The company operates through numerous subsidiaries and joint ventures worldwide to strengthen its market position and distribution network.

Key Areas of Operation

  1. Regulatory Compliance:
    • Quality Standards: Aurobindo adheres to stringent quality control measures and regulatory requirements to ensure the safety, efficacy, and quality of its products.
    • Approvals and Inspections: The company regularly undergoes inspections by regulatory authorities such as the FDA, EMA, and others to maintain compliance with international standards.
  2. Research and Development:
    • Innovation: Aurobindo’s R&D efforts are focused on developing complex generics, novel drug delivery systems, and biosimilars.
    • Pipeline: The company has a robust pipeline of products in various stages of development, aimed at addressing unmet medical needs and expanding its market offerings.
  3. Manufacturing Excellence:
    • Capacity: Aurobindo’s manufacturing facilities are equipped with advanced technology and have large production capacities, enabling the company to meet global demand efficiently.
    • Vertical Integration: The company’s vertical integration in API and formulation manufacturing provides cost advantages and ensures consistent supply chain management.
  4. Strategic Acquisitions and Partnerships:
    • Expansion: Aurobindo has expanded its global footprint through strategic acquisitions and partnerships, enhancing its product portfolio and market access.
    • Notable Acquisitions: Examples include the acquisition of Sandoz’s U.S. dermatology and oral solids businesses, and Apotex’s businesses in select European countries.

Corporate Responsibility

  1. Sustainability:
    • Environmental Practices: Aurobindo is committed to sustainable manufacturing practices, including reducing its carbon footprint, efficient waste management, and water conservation efforts.
    • Community Initiatives: The company engages in various CSR activities focused on healthcare, education, and community development.
  2. Employee Welfare:
    • Workplace Safety: Aurobindo places a strong emphasis on workplace safety, health, and well-being of its employees.
    • Training and Development: The company invests in continuous training and professional development for its workforce.

Conclusion

Aurobindo Pharma is a prominent global pharmaceutical company known for its extensive range of generic medications and APIs. With a strong focus on research and development, regulatory compliance, and strategic growth, Aurobindo continues to expand its global presence and product portfolio. The company’s commitment to quality, innovation, and sustainability positions it as a key player in the pharmaceutical industry, contributing to making healthcare more affordable and accessible worldwide.